Adding peginterferon alfa-2a to entecavir increases HBsAg decline and HBeAg clearance - first results from a global randomized trial (ARES study)

被引：0

作者：

Sonneveld, Milan J. ^{[1
]}

Xie, Qing ^{[2
]}

Zhang, Ning-Ping ^{[3
]}

Zhang, Qin ^{[4
]}

Tabak, Fehmi ^{[5
]}

Streinu-cercel, Adrian ^{[6
]}

Wang, Jiyao ^{[3
]}

Idilman, Ramazan ^{[7
]}

de Niet, Annikki ^{[8
]}

Diculescu, Mircea. ^{[9
]}

van Vuuren, Anneke J. ^{[1
]}

Verhey, Elke ^{[1
]}

Hansen, Bettina E. ^{[1
]}

Janssen, Harry L. ^{[1
]}

机构：

[1] Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam, Netherlands

[2] Jiao Tong Univ, Ruijin Hosp, Shanghai 200030, Peoples R China

[3] Fu Dan Univ, Zhong Shan Hosp, Shanghai, Peoples R China

[4] Fu Dan Univ, Shanghai Publ Hlth Ctr, Shanghai, Peoples R China

[5] Cerrahpasa Med Sch, Istanbul, Turkey

[6] Natl Inst Infect Dis, Bucharest, Romania

[7] Ankara Univ, TR-06100 Ankara, Turkey

[8] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands

[9] Fundeni Cinical Inst, Bucharest, Romania

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：199A / 200A

页数：2